Nektar Therapeutics
Symbol: NKTR
NASDAQ
0.9
USDMarket price today
-1.0381
P/E Ratio
-0.0148
PEG Ratio
165.26M
MRK Cap
- 0.00%
DIV Yield
Nektar Therapeutics Management Structure
Management information
Name | Title |
---|---|
Ms. Sandra A. Gardiner | Interim Chief Financial Officer |
Mr. Mark A. Wilson | Senior Vice President, Chief Legal Officer & Secretary |
Dr. Jonathan Zalevsky Ph.D. | Chief Research & Development Officer |
Dr. Mary Tagliaferri L.Ac., M.D. | Chief Medical Officer |
Ms. Jennifer Ruddock | Chief Business Officer |
Mr. Howard W. Robin | Chief Executive Officer, President & Director |
Mr. Robert Bacci | Senior Vice President of Human Resources & Facilities Operations |
Vivian Wu | Director of Investor Relations & Corporate Affairs |
Similar Stocks
You may also be interested in:SRNE
Top management:
- Dr. Scott Schaus
- Dr. Henry H. Ji P...
MRVI
Top management:
- Ms. Debra Hart
- Ms. Rebecca Buzzeo
- Dr. Kate E. Brode...
CMRA
Top management:
- Ms. Janice Marie ...
- Dr. David Soane ...
- Mr. Michael G. Ca...
GUBRA.CO
Top management:
- Ms. Trine Nygaard...
- Mr. Kristoffer R...
- Ms. Margit Bloch ...
T5O.DE
Top management:
- Dr. Mark-André F...
- Dr. Dirk Kaiser
- Dr. Bruno Rosen
6826.HK
Top management:
- Ms. Caixia Ren
- Mr. Ming King Ch...
- Ms. Min Tian
PPBT
Top management:
- Mr. Ido Morpurgo...
- Mr. Lior Fhima C...
- Dr. Michael Schi...